296 related articles for article (PubMed ID: 12174959)
21. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.
Spiegler BJ; Kennedy K; Maze R; Greenberg ML; Weitzman S; Hitzler JK; Nathan PC
J Clin Oncol; 2006 Aug; 24(24):3858-64. PubMed ID: 16921038
[TBL] [Abstract][Full Text] [Related]
22. Temporal lobe epilepsy with hippocampal sclerosis in acute lymphoblastic leukemia.
Kasai-Yoshida E; Ogihara M; Ozawa M; Nozaki T; Morino M; Manabe A; Hosoya R
Pediatrics; 2013 Jul; 132(1):e252-6. PubMed ID: 23776122
[TBL] [Abstract][Full Text] [Related]
23. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization.
Winter SS; Dunsmore KP; Devidas M; Wood BL; Esiashvili N; Chen Z; Eisenberg N; Briegel N; Hayashi RJ; Gastier-Foster JM; Carroll AJ; Heerema NA; Asselin BL; Gaynon PS; Borowitz MJ; Loh ML; Rabin KR; Raetz EA; Zweidler-Mckay PA; Winick NJ; Carroll WL; Hunger SP
J Clin Oncol; 2018 Oct; 36(29):2926-2934. PubMed ID: 30138085
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal methotrexate-induced acute chorea.
Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity.
Shuper A; Stark B; Kornreich L; Cohen IJ; Aviner S; Steinmetz A; Stein J; Goshen Y; Yaniv I
J Child Neurol; 2000 Sep; 15(9):573-80. PubMed ID: 11019787
[TBL] [Abstract][Full Text] [Related]
26. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
Mahoney DH; Shuster J; Nitschke R; Lauer SJ; Winick N; Steuber CP; Camitta B
J Clin Oncol; 1998 Jan; 16(1):246-54. PubMed ID: 9440749
[TBL] [Abstract][Full Text] [Related]
27. Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer S; Steuber CP; Camitta B
J Clin Oncol; 2000 Mar; 18(6):1285-94. PubMed ID: 10715299
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of acute lymphoblastic leukemia in children according to the ALL-BFM-90m protocol in the Russian Federation and the Republic of Belarus].
Miakova NV; Aleĭnikova OV; Hartmann R; Rudneva AE; Trubina NM; Fechina LG; Timakov AM; Shamardina AV; Lebedev VV; Varfolomeeva SIu; Dudkin SD; Dyshlevaia ZM; Timofeeva VN; Rumiantsev AG; Henze H; Karachunskiĭ AI
Vopr Onkol; 2002; 48(3):347-51. PubMed ID: 12455360
[TBL] [Abstract][Full Text] [Related]
29. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
[TBL] [Abstract][Full Text] [Related]
30. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
[TBL] [Abstract][Full Text] [Related]
31. [Neurological and psychological sequelae in children with acute lymphoblastic leukemia who had received radiotherapy and intrathecal methotrexate].
Bernáldez-Ríos R; Villasís-Keever MA; Beltrán-Adame G; García-Ramírez R; Rodríguez-Zepeda MC; Hermida-Gutiérrez I; Arias-Gómez J; Cruz-Luna E
Gac Med Mex; 1998; 134(2):153-9. PubMed ID: 9618994
[TBL] [Abstract][Full Text] [Related]
32. Demyelination and single-carbon transfer pathway metabolites during the treatment of acute lymphoblastic leukemia: CSF studies.
Surtees R; Clelland J; Hann I
J Clin Oncol; 1998 Apr; 16(4):1505-11. PubMed ID: 9552059
[TBL] [Abstract][Full Text] [Related]
33. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia.
Wolfrom C; Hartmann R; Fengler R; Brühmüller S; Ingwersen A; Henze G
J Clin Oncol; 1993 May; 11(5):827-33. PubMed ID: 8487046
[TBL] [Abstract][Full Text] [Related]
34. Experience with high dose methotrexate therapy in childhood acute lymphoblastic leukemia in a tertiary care cancer centre of a developing country.
Kapoor G; Sinha R; Abedin S
Pediatr Blood Cancer; 2012 Sep; 59(3):448-53. PubMed ID: 22271707
[TBL] [Abstract][Full Text] [Related]
35. Intelligence quotient in childhood acute lymphoblastic leukemia after prophylactic treatment in central nervous system with 18 Gy cranial irradiation and intrathecal methotrexate.
Liu HC; Liang DC; Chen SH; Lo CY; Tseng KP; Kuo TB; Chen HJ; Wang SJ
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(2):107-10. PubMed ID: 8935408
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation.
Hill JM; Kornblith AB; Jones D; Freeman A; Holland JF; Glicksman AS; Boyett JM; Lenherr B; Brecher ML; Dubowy R; Kung F; Maurer H; Holland JC
Cancer; 1998 Jan; 82(1):208-18. PubMed ID: 9428499
[TBL] [Abstract][Full Text] [Related]
37. [Late sequelae of CNS recurrence of acute lymphoblastic leukemia in childhood].
Steinberg S; Hartmann R; Wisniewski S; Berger K; Beck JD; Henze G
Klin Padiatr; 1998; 210(4):200-6. PubMed ID: 9743953
[TBL] [Abstract][Full Text] [Related]
38. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
[TBL] [Abstract][Full Text] [Related]
39. Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Widemann BC; Balis FM; Murphy RF; Sorensen JM; Montello MJ; O'Brien M; Adamson PC
J Clin Oncol; 1997 May; 15(5):2125-34. PubMed ID: 9164227
[TBL] [Abstract][Full Text] [Related]
40. Delayed elimination of high-dose methotrexate and use of carboxypeptidase G2 in pediatric patients during treatment for acute lymphoblastic leukemia.
Svahn T; Mellgren K; Harila-Saari A; Åsberg A; Kanerva J; Jónsson Ó; Vaitkeviciene G; Stamm Mikkelssen T; Schmiegelow K; Heldrup J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
